Bleeding News and Research

RSS

Regado's REG1 system Phase 2b trial results presented at i2 Summit

Regado Biosciences, Inc., a privately held company pioneering the development of antithrombotic aptamers with active control agents, announced today the primary results of the RADAR Phase 2b clinical trial of the company's lead product, the anticoagulation system REG1, at the i2 Summit during the American College of Cardiology 2011 60th Annual Scientific Session & Expo in New Orleans, LA.

4 Apr 2011

Omeros announces outcome from OMS103HP Phase 3 study in patients undergoing ACL surgery

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today reported the outcome from its Phase 3 program evaluating OMS103HP in patients undergoing arthroscopic anterior cruciate ligament reconstruction surgery.

1 Apr 2011

Routine sonograms after IUD insertion can reduce pregnancy complications

A retrospective study of women who became pregnant while using intrauterine devices shows that more than half of the IUDs were malpositioned.

30 Mar 2011

Pelvic arterial embolization therapy effective treatment for postpartum hemorrhage

Pelvic arterial embolization or PAE, a minimally invasive, life-saving therapy, is a safe and effective treatment for postpartum hemorrhage, say researchers at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago, Ill.

30 Mar 2011

Navy sonar experts develop new medical device for stroke detection

A medical device developed by retired U.S. Navy sonar experts, using submarine technology, is a new paradigm for the detection, diagnosis and monitoring of stroke, says a team of interventional radiologists at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago, Ill.

30 Mar 2011

ACCF, AHA guidelines recognize Effient as Class I treatment option for patients with ACS-PCI

Oral antiplatelet therapy Effient has been added to the updated clinical practice guidelines as a Class I recommended treatment option for patients undergoing percutaneous coronary intervention fter experiencing heart-related chest pain at rest or non-ST segment elevation myocardial infarction.

30 Mar 2011

Uterine fibroid embolization reduces fibroid-related urinary symptoms

Uterine fibroid embolization—an interventional radiology treatment for the noncancerous yet very common growths that develop in the muscular wall of the uterus—improves a number of women's lower urinary tract problems that are specifically caused by those fibroids, confirm researchers at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago, Ill.

30 Mar 2011

Natural disasters can produce major lung problems

A comprehensive new review published in the journal Respirology indicates that lung problems are major causes of morbidity and mortality following natural disasters.

29 Mar 2011

UC San Diego student to make medical imaging available in low-income countries

Benjamin Johnson, a fourth-year student at the University of California, San Diego School of Medicine is determined to make medical imaging technology widely available in low-income countries. His journey started in Uganda, where currently just 35 local radiologists serve the needs of 30 million people.

29 Mar 2011

Inflammatory bowel disease in children - Delays in diagnosis common

Once a medical rarity in children, inflammatory bowel disease today is increasingly common in kids, but many of them may not be diagnosed in a timely manner, according to experts from the Pediatric Inflammatory Bowel Disease Center at Johns Hopkins Children’s Center.

28 Mar 2011

Swallowed button battery can generate electrical current and cause serious tissue damage

To mark National Poison Prevention week, Trauma specialists at The Montreal Children's Hospital (MCH) of the McGill University Health Centre are urging parents to seek immediate medical attention if their child has swallowed a button battery. Parents should not assume the tiny battery will harmlessly pass through their child's system.

25 Mar 2011

Merck to return rights for betrixaban to Portola

Portola Pharmaceuticals and Merck, known as MSD outside the United States and Canada, today announced that Merck plans to return to Portola all rights for betrixaban, an investigational oral Factor Xa inhibitor anticoagulant being evaluated for the prevention of stroke in patients with atrial fibrillation (SPAF). This decision was made following a review of Merck's investigational portfolio.

25 Mar 2011

'Consent rituals' cause life-threatening delays

Current rules requiring researchers to obtain consent for patients to take part in clinical trials in emergency situations are causing life-threatening delays to treatment, experts have argued.

25 Mar 2011

Dabigatran etexilate is less costly, more effective for stroke treatment in patients with AF

A new economic analysis, published online in Thrombosis and Haemostasis, suggested that Boehringer Ingelheim's novel oral direct thrombin inhibitor dabigatran etexilate is cost-effective compared to current treatment options, particularly in real-world clinical practice.

25 Mar 2011

BioCer to showcase plant-based hemostasis and coated hernia repair technologies to China.

BioCer Entwicklungs GmbH, a Bayreuth, Germany based medical device manufacturer, has announced their attendance at the China Medical Equipment Fair (CMEF) Shenzhen, China 15th-19th April 2011. HaemoCer™ an Absorbable Polysaccharide Hemostat (APH) and Ti0²Mesh™ Hernia repair system will be on exhibit at the BioCer booth.

24 Mar 2011

New study: Prostate and breast cancer usually recur in bone

Like bad neighbors who decide to go wreck another community, prostate and breast cancer usually recur in the bone, according to a new University of Michigan study.

24 Mar 2011

Rapid treatment within an hour of injury dramatically cuts bleeding deaths in injured patients

An hour can make the difference between life and death when using tranexamic acid to treat injured patients with severe bleeding, a study by researchers at the London School of Hygiene & Tropical Medicine suggests.

24 Mar 2011

Positive data from Omeros' OMS302 Phase 2b trial in patients undergoing cataract surgery

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today reported positive data from a Phase 2b clinical trial evaluating OMS302 in patients undergoing cataract surgery.

23 Mar 2011

NIH: Diabetic retinopathy leads to vision loss in working-age Americans

Diabetes is often called the "silent killer" because people who have it are often unaware they are affected. According to the American Diabetes Association, diabetes affects 26 million people – including children – in the United States. Approximately one-quarter of those people do not know they're living with the disease.

23 Mar 2011

WHO releases first list of 30 priority medicines for women, children

The WHO on Monday released a list of 30 medicines that "are essential for treating common diseases of mothers and children," Ghana News Agency reports (3/21).

23 Mar 2011

Bleeding News and Research

Regado's REG1 system Phase 2b trial results presented at i2 Summit

Omeros announces outcome from OMS103HP Phase 3 study in patients undergoing ACL surgery

Routine sonograms after IUD insertion can reduce pregnancy complications

Pelvic arterial embolization therapy effective treatment for postpartum hemorrhage

Navy sonar experts develop new medical device for stroke detection

ACCF, AHA guidelines recognize Effient as Class I treatment option for patients with ACS-PCI

Uterine fibroid embolization reduces fibroid-related urinary symptoms

Natural disasters can produce major lung problems

UC San Diego student to make medical imaging available in low-income countries

Inflammatory bowel disease in children - Delays in diagnosis common

Swallowed button battery can generate electrical current and cause serious tissue damage

Merck to return rights for betrixaban to Portola

'Consent rituals' cause life-threatening delays

Dabigatran etexilate is less costly, more effective for stroke treatment in patients with AF

BioCer to showcase plant-based hemostasis and coated hernia repair technologies to China.

New study: Prostate and breast cancer usually recur in bone

Rapid treatment within an hour of injury dramatically cuts bleeding deaths in injured patients

Positive data from Omeros' OMS302 Phase 2b trial in patients undergoing cataract surgery

NIH: Diabetic retinopathy leads to vision loss in working-age Americans

WHO releases first list of 30 priority medicines for women, children

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News